The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Badeĭnikova K.K.

FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Petroverigskiĭ pereulok

Mamedov M.N.

Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny, Moskva

The main points of the European guidelines for the prevention of cardiovascular diseases in clinical practice (a review of literature)

Authors:

Badeĭnikova K.K., Mamedov M.N.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2014;17(4): 25‑32

Read: 4159 times


To cite this article:

Badeĭnikova KK, Mamedov MN. The main points of the European guidelines for the prevention of cardiovascular diseases in clinical practice (a review of literature). Russian Journal of Preventive Medicine. 2014;17(4):25‑32. (In Russ.)

References:

  1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 25: 3143-3421.
  2. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635-1701.
  3. European Heart Network. Eur Cardiovasc Dis Stat. 2008.
  4. Oganov R.G., Maslennikova G.Ya., Koltunov I.E., Kalinina A.M. Neobkhodimye usloviya dlya profilaktiki serdechno-sosudistykh I drugikh neinfektsionnykh zabolevaniy v Rossiyskoy Federatsii [The indispensable conditions or the prevention of cardiovascular and other non-infectious diseases in the Russian Federation]. Terap I prof 2010; 9: 6: 4-9. [In Russ.].
  5. Starodubov V.I., Ivanova A.V., Semina V.G., et al. Zdorov'e natsii. Dinamika I prognozy zdorov'ya naseleniya Rossii v sotsial"nom kontekste 90-kh godov XX veka [The health of the nation. Dynamics and prognoses of the health status of the population of Russia in the social context in the1990s of the XXth century]. Glavvrach2002; 8: 13-32. [In Russ.].
  6. Kalinina A.M., Pozdnyakov Yu.M., Eganyan R.A. Stabil'naya stenokardiya. Pod red. R.G. Oganova [Stable angina. Ed. R.G. Oganov]. M 2010. [In Russ.].
  7. Bolezni Serdtsa I sosudov. Rukovodstvo Evropeiskogo obshchestva kardiologov. Pod red. A. D. Camm, Th. F. Luscher, and P. W. Serruys. Per. s angl. Pod red. E.V. Shlyakhto [The diseases of heart and vessels. The ESC Textbook of Cardiovascular Medicine. Eds. A. D. Camm, Th. F. Luscher, and P. W. Serruys. Transl. from English. Ed. E.V. Shlyakhto]. M 2011. [In Russ.].
  8. World Health Organization. Joint WHO/FAO Expert Consultation on Diet. Nutrit Prevent Chron Dis 2002.
  9. Puska P. Successful strategies to influence national diets: the Finnish experience. Zdrav Var 2003; 43: 191-196.
  10. Shal'nova S.A., Kalinina A.M., Martsevich S.Yu., Karmanova N.S., Fedotova A.V. Profilaktika serdechno-sosudistykh zabolevaniy v klinicheskoy praktile [Prevention of cardiovascular diseases in clinical practice]. M 2009. [In Russ.].
  11. Oganov R.G., Shal'nova S.A., Kalinina A.M. Profilaktika serdechno-sosudistykh zabolevaniy: rukovodstvo [Prevention of cardiovascular diseases in clinical practice: the guidelines]. M 2009. [In Russ.].
  12. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32-38.
  13. Artinian N.T., Fletcher G.F., Mozaffarian D., Kris-Etherton P., Van Horn L., Lichtenstein A.H., Kumanyika S., Kraus W.E., Fleg J.L., Redeker N.S., Meininger J.C., Banks J., Stuart-Shor E.M., Fletcher B.J., Miller T.D., Hughes S., Braun L.T., Kopin L.A., Berra K., Hayman L.L., Ewing L.J., Ades P.A., Durstine J.L., Houston-Miller N., Burke L.E. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 2010; 122: 406-441.
  14. Piepoli M.F., Corra U., Benzer W., Bjarnason-Wehrens B., Dendale P., Gaita D., McGee H., Mendes M., Niebauer J., Zwisler A.D., Schmid J.P. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2010; 17: 1-17.
  15. Prescott E., Hippe M., Schnohr P., Hein H.O., Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043-1047.
  16. Mucha L., Stephenson J., Morandi N., Dirani R. Metaanalysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 2006; 3: 279-291.
  17. Prescott E., Scharling H., Osler M., Schnohr P. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study. J Epidem Com Health 2002; 56: 702-706.
  18. Center for Disease Control and Prevention. How Tobacco Smoke Causes Disease: The Biology and Behavioural Basis for Smoking-attributable Disease. Report Surg Gen 2010.
  19. Law M.R., Morris J.K., Wald N.J. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 1997; 315: 973-980.
  20. International Agency for Research on Cancer. Tobacco Control' Reversal of Risk After Quitting Smoking. IARC Handbooks of Cancer Prevention. Lyon: IARC 2007; 11.
  21. Wu J., Ho S., Zhou C. et al. Coffee consumption and risk of coronary heart diseases: A meta-analysis of 21 prospective cohort studies. Int J Cardiol 2009; 137: 216.
  22. Knowler W., Barrett-Connor E., Fowler S. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393.
  23. Yakushin S., Filippov E. Profilaktika serdechno-sosudistykh zabolevaniy: kurs na zdorovy obraz zhizni [The prevention of cardiovascular diseases; toward the healthy lifestyle]. Vrach 2011; 9: 2-7. [In Russ.].
  24. Whitlock G., Lewington S., Sherliker P., Clarke R., Emberson J., Halsey J., Qizilbash N., Collins R., Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
  25. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
  26. Gradman A.H., Schmieder R.E., Lins R.L., Nussberger J., Chiang Y., Bedigian M.P. Aliskiren, a novel orally effective renin inhibitor provides dose-dependent antihypertensive efficacy placebo-like tolerability in hypertensive patients. Circulation 2005; 111: 1012-1018.
  27. Mamedov M.N. Shkola po diagnostike I lecheniyu giperlipidemii [The school of diagnostics and treatment of hyperlipidemia]. M. 2006. [In Russ.].
  28. Ho P.M., Bryson C.L., Rumsfeld J.S. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-3035.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.